124 related articles for article (PubMed ID: 1909607)
21. Persistence of impaired PRL responses to sulpiride in patients with PRL secreting pituitary adenomas after successful hypophysectomy.
Hanew K; Sasaki A; Sato S; Kasai M; Murata K; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1983 Jul; 140(3):225-33. PubMed ID: 6414103
[TBL] [Abstract][Full Text] [Related]
22. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma.
Marrs RP; Bertolli SJ; Kletzky OA
Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812
[TBL] [Abstract][Full Text] [Related]
23. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Jeske W
Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
[TBL] [Abstract][Full Text] [Related]
24. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
25. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
26. Prolactin-secreting adenomas: surgical results and long-term follow-up.
Maira G; Anile C; De Marinis L; Barbarino A
Neurosurgery; 1989 May; 24(5):736-43. PubMed ID: 2716983
[TBL] [Abstract][Full Text] [Related]
27. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.
Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Sgrò M; Franchi F; Luisi M
Horm Res; 1989; 31(3):133-7. PubMed ID: 2501208
[TBL] [Abstract][Full Text] [Related]
28. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
29. Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.
Bohnet HG; Hanker JP; Horowski R; Wickings EJ; Schneider HP
Acta Endocrinol (Copenh); 1979 Sep; 92(1):8-19. PubMed ID: 386688
[TBL] [Abstract][Full Text] [Related]
30. [Prolactin variants in serum and amniotic fluid of women with ovulatory hyperprolactinemia].
Larrea F; Escorza A; Méndez I; Ruiz JE; Valero A; Cravioto MC
Rev Invest Clin; 1991; 43(3):245-51. PubMed ID: 1818370
[TBL] [Abstract][Full Text] [Related]
31. Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours.
Schlechte JA; Sherman BM
Clin Endocrinol (Oxf); 1981 Aug; 15(2):165-74. PubMed ID: 6796301
[TBL] [Abstract][Full Text] [Related]
32. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method.
Tallen G; Fehr S; Saeger W; Uhlig H; Lüdecke DK
Acta Endocrinol (Copenh); 1993 May; 128(5):411-7. PubMed ID: 8317187
[TBL] [Abstract][Full Text] [Related]
33. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G
Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607
[TBL] [Abstract][Full Text] [Related]
34. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
35. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
[TBL] [Abstract][Full Text] [Related]
36. A normal ovulatory woman with hyperprolactinemia: presence of anti-prolactin autoantibody and the regulation of prolactin secretion.
Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
Acta Endocrinol (Copenh); 1992 Jun; 126(6):497-500. PubMed ID: 1642083
[TBL] [Abstract][Full Text] [Related]
37. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels.
Kovacs CS; Chik CL
J Clin Endocrinol Metab; 1995 Oct; 80(10):3036-42. PubMed ID: 7559893
[TBL] [Abstract][Full Text] [Related]
38. Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women.
Venturini PL; Horowski R; Valenzano M; Costantini S; Fasce V; Gorlero F; Rainer E; De Cecco L
Eur J Clin Pharmacol; 1986; 30(2):195-7. PubMed ID: 3709645
[TBL] [Abstract][Full Text] [Related]
39. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
[TBL] [Abstract][Full Text] [Related]
40. Effect of GnRH-associated peptide on prolactin secretion from human lactotrope adenoma cells in culture.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T; Toyama M; Kamoi K
Acta Endocrinol (Copenh); 1987 Sep; 116(1):81-4. PubMed ID: 3310494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
